information on new approvals and medication safety
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
Newly Discovered Molecule Modulates Cartilage Repair
Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.
ACA Upheld: What Does This Mean for Rheumatology?
What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?
High-Impact Rheumatology Practice Redesign
It’s time to start adapting your practice to changes in the healthcare system.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
Rheumatology Students Learning How To Look for Symptoms
First impressions and presumptions can lead us astray if we don’t pay attention.
The American Board of Bada Bing
CME, recertification—what really gets quality results?
AMA House of Delegates Meeting: Decisions Affecting You
An overview of some of the issues that were covered during the June 2012 American Medical Association House of Delegates meeting to debate policy.
- « Previous Page
- 1
- …
- 668
- 669
- 670
- 671
- 672
- …
- 807
- Next Page »